CorMedix (CRMD) Total Liabilities (2010 - 2026)
CorMedix (CRMD) posted Total Liabilities of $420.8 million for Q4 2025, up 11.71% sequentially from $376.7 million in Q3 2025, and up 1130.91% YoY from $34.2 million in Q4 2024.
CorMedix (CRMD) Total Liabilities (2010 - 2026) Analysis & Trends
CorMedix has reported Total Liabilities for 15 years, with the latest figure at $420.8 million in Q4 2025.
- Quarterly Total Liabilities rose 1130.91% year-over-year to $420.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $420.8 million (up 1130.91% YoY) and the FY2025 annual result came in at $420.8 million, up 1130.91% from the prior year.
- Total Liabilities advanced to $420.8 million in Q4 2025 per CRMD's latest filing, from $376.7 million in the prior quarter.
- Over five years, Total Liabilities peaked at $420.8 million in Q4 2025 and troughed at $3.9 million in Q1 2021.
- A 5-year average of $50.8 million and a median of $8.1 million in 2023 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2021 and 2025: Total Liabilities plunged 32.08% in 2021, then soared 1896.05% in 2025.
- Over 5 years, Total Liabilities stood at $6.1 million in 2021, then increased by 13.52% to $7.0 million in 2022, then soared by 70.77% to $11.9 million in 2023, then soared by 186.88% to $34.2 million in 2024, then surged by 1130.91% to $420.8 million in 2025.
- According to Business Quant data, Total Liabilities over the past three periods registered $420.8 million, $376.7 million, and $32.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 10.03 Bn |
| 10 | CorMedix | 645.20 Mn | 388.51 Mn | 77.13 Mn | 443.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 443.22 Mn |
| Dec 31, 2025 | 420.84 Mn |
| Sep 30, 2025 | 376.73 Mn |
| Jun 30, 2025 | 31.97 Mn |
| Mar 31, 2025 | 34.69 Mn |
| Dec 31, 2024 | 34.19 Mn |
| Sep 30, 2024 | 18.87 Mn |
| Jun 30, 2024 | 11.55 Mn |
| Mar 31, 2024 | 10.01 Mn |
| Dec 31, 2023 | 11.92 Mn |
| Sep 30, 2023 | 8.23 Mn |
| Jun 30, 2023 | 7.98 Mn |
| Mar 31, 2023 | 5.31 Mn |
| Dec 31, 2022 | 6.98 Mn |
| Sep 30, 2022 | 5.76 Mn |
| Jun 30, 2022 | 6.01 Mn |
| Mar 31, 2022 | 5.06 Mn |
| Dec 31, 2021 | 6.15 Mn |
| Sep 30, 2021 | 6.05 Mn |
| Jun 30, 2021 | 3.99 Mn |